Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2015

Mar 2, 2015

30826_dirs_2015-03-02_99d3c04d-ac2d-4922-8e13-448318953415.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2015-02-26

Reporting Person: Hunt Anthony (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-26 Common Stock A 20267 $0.00 Acquired 45267 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-26 Stock Option (Right to Buy) $24.98 A 39037 Acquired 2025-02-26 Common Stock (39037) Direct

Footnotes

F1: Mr. Hunt was awarded 20,276 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.

F2: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.